Will the media be forever obsessed with cancer risk? How can we separate fact from fiction in the miles of accumulated column inches amassed by cancer stories every year?
Breast cancer was a neglected disease for so long, and it may still be for half the population; why don't we hear more about breast cancer in men? How prevalent is it?
Finally, what does the future of cancer care look like? How much of the hope for better-targeted treatments launched by the genomic revolution is legitimate and how much is hot air? Will the burgeoning discipline of epigenetics play a role?
Does the pharmaceutical and biotech industry's profit motive actually pervert rather than inspire innovation and the hunt for new therapies? Is the patent system well suited to a new life sciences landscape including stem cell and gene therapies?...
Is the benefit attributed to widespread breast cancer screening programmes supported by the evidence? What to make of the phenomenon of overdiagnosis, where patients are treated for cancers that would not have spread or been problematic in their lifetime?...
Progress Educational Trust, 140 Grays Inn Road, London WC1X 8AX, UK
Tel: +44 (0)20 7278 7870 Email: firstname.lastname@example.org
Limited company registered in England and Wales no 07405980
Registered charity no 1139856